Présentation de l'entreprise
Zhongchao Inc., identified by the ticker ZCMD, operates within the healthcare sector specifically as a provider of health information services. The company delivers healthcare information, education, and training services to healthcare professionals in the People's Republic of China under its MDMOOC brand. Its operational scope is segmented into two distinct areas: MDMOOC services and the sales of patented drugs, which also includes patient management services. With a market capitalization of $7.42M and annual revenue of $11.37M, the company functions on a small scale relative to large-cap peers. The combination of a sub-$10M market cap and single-digit million revenue stream indicates that Zhongchao Inc. occupies a niche position rather than a dominant market share. The absence of available employee data further suggests a lean operational structure typical of specialized service providers in the health information industry. These valuation metrics collectively position the entity as a micro-cap stock with limited operational footprint and specialized service offerings in the Chinese healthcare market.
Santé financière
Zhongchao Inc. reported a revenue of $11.37M over the trailing twelve months, yet it recorded a net income of $-6,310,153, revealing a severe disconnect between top-line generation and bottom-line profitability. The EBITDA stood at $-5,901,042, indicating that operating expenses significantly exceeded operating revenues before interest and taxes. This substantial gap between positive revenue and negative net income highlights a cost structure where operating costs, likely driven by high burn rates or significant one-time expenses, consume the majority of generated income. The company's free cash flow was $-1,112,632, demonstrating a lack of financial flexibility to fund capital expenditures or debt service from current operations without external financing. Despite generating negative operating cash flow, the balance sheet remains robust with cash holdings of $13.92M against a minimal debt load of $26,083. The debt-to-equity ratio of 0.12 confirms that the company maintains a highly conservative balance sheet with negligible leverage. Liquidity is exceptionally strong, evidenced by a current ratio of 11.11, which suggests the firm holds more than eleven times the current assets necessary to cover its short-term liabilities. However, the return on equity is -24.9% and the return on assets is -15.5%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate profits.
Évaluation de la valorisation
The trailing twelve-month P/E ratio is N/A due to the negative earnings, while the forward P/E is also N/A, meaning traditional earnings-based valuation multiples cannot be applied to assess the expected earnings trajectory. The price-to-book ratio stands at 0.30, indicating that the market values the company at significantly less than the replacement cost of its tangible assets. The price-to-sales ratio is 0.65, suggesting the market prices the revenue stream at less than two-thirds of its nominal value. The EV/EBITDA multiple is 0.42, an extremely low figure that reflects the negative earnings but also highlights the asset-heavy or cash-rich nature of the balance sheet relative to its valuation. The stock has exhibited significant volatility, with a 52-week high of $12.18 and a 52-week low of $1.44. Without a specific current share price provided in the facts, the range indicates a wide band of potential price discovery, though the low valuation multiples suggest the market has priced in the risk of continued losses. The beta is listed as N/A, preventing an assessment of price volatility relative to the broader market index. These alternative valuation metrics provide a clearer picture than earnings multiples, showing the market is focusing on asset value and sales generation rather than profitability.
Growth & Income
Zhongchao Inc. experienced a revenue growth rate of -23.2% year-over-year, while the earnings growth rate is N/A due to the lack of positive earnings history for calculation. The contraction in revenue implies that the company is shrinking its top line, and without positive earnings, the concept of earnings growing faster or slower than revenue is currently inapplicable. The company does not pay dividends, as indicated by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests its earnings, or rather its cash reserves, into growth initiatives rather than distributing income to shareholders. The overall growth and income profile is characterized by declining revenue, negative earnings, and a non-dividend strategy that relies entirely on the $13.92M cash reserve to fund future operations and potentially reverse the negative revenue trend.